SIRT1 Gene Polymorphism With Premature Myocardial Infarction in Young Egyptian Patients
Launched by SOHAG UNIVERSITY · Dec 6, 2021
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patient with recent MI admitted to Sohag University Hospital , CCU under 40 years
- Exclusion Criteria:
- • patients above 40 year old.
- • Patients with malignancies, major trauma or surgery in the previous six months, and acute or chronic infectious disease
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Trial Officials
Amera Morad Foad hamdy, lecturer
Principal Investigator
Sohag faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials